RT Journal Article
SR Electronic
T1 630 EO2401, a new peptide immunotherapy against cancer, in combination with nivolumab, induces a strong and durable immune response in patients from the EOADR1–19/SPENCER study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A719
OP A719
DO 10.1136/jitc-2023-SITC2023.0630
VO 11
IS Suppl 1
A1 Aubergeon, Lucie
A1 Baudin, Eric
A1 Berruti, Alfredo
A1 Grisanti, Salvatore
A1 Oordt, CWillemien Menke-vander Houven van
A1 Haak, Harm
A1 Fassnacht, Martin
A1 Capdevila, Jaume
A1 Subbiah, Vivek
A1 Jimenez, Camilo
A1 Fouchardière, Christelle de la
A1 Granberg, Dan
A1 Kroiss, Matthias
A1 Daugaard, Gedske
A1 Toussaint, Hélène
A1 Magalhaes, Joao Gamelas
A1 Martinez, Jennifer
A1 Belyn, Camille
A1 Kervevan, Jerome
A1 Ventujol, Chloé
A1 Bonny, Christophe
A1 Paillarse, Jean-Michel
A1 Chene, Laurent
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A719.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.